The immoral gene: does it really exist?
Over the last years several European patents were opposed for protecting technology violating the morality requirement under Article 53(a) EPC. Attempts have been made by the Appeal Boards of the European Patent Office (EPO), as well as by amendments introduced into the Implementing Regulations of the European Patent Convention (EPC), to address this sensitive patentability requirement more precisely. The most recent hot topic coming up in this context is the patentability of stem cells. It is to be expected that this discussion will still go on in the field of biotechnological inventions for the next several years.
Zimmer
Franz-Josef
FJ
Grünecker, Kinkeldey, Stockmair & Schwanhäusser, Law Firm, Munich, Germany. zimmer@grunecker.de
Sethmann
Svenja
S
D001675:Bioethics; D001709:Biotechnology / Q000941:ethics*; D005062:European Union; D006801:Humans; D009014:Morals; D010330:Patents as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence*